223 related articles for article (PubMed ID: 32986992)
1. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
Burwick RM; Feinberg BB
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1059-S1070. PubMed ID: 32986992
[TBL] [Abstract][Full Text] [Related]
2. Complement Activation and Thrombotic Microangiopathies.
Palomo M; Blasco M; Molina P; Lozano M; Praga M; Torramade-Moix S; Martinez-Sanchez J; Cid J; Escolar G; Carreras E; Paules C; Crispi F; Quintana LF; Poch E; Rodas L; Goma E; Morelle J; Espinosa M; Morales E; Avila A; Cabello V; Ariceta G; Chocron S; Manrique J; Barros X; Martin N; Huerta A; Fraga-Rodriguez GM; Cao M; Martin M; Romera AM; Moreso F; Manonelles A; Gratacos E; Pereira A; Campistol JM; Diaz-Ricart M
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1719-1732. PubMed ID: 31694864
[TBL] [Abstract][Full Text] [Related]
3. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.
Yonekura Collier AR; Zsengeller Z; Pernicone E; Salahuddin S; Khankin EV; Karumanchi SA
Hypertens Pregnancy; 2019 Aug; 38(3):193-199. PubMed ID: 31291799
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
Haeger M; Unander M; Bengtsson A
Obstet Gynecol; 1990 Oct; 76(4):698-702. PubMed ID: 2216207
[TBL] [Abstract][Full Text] [Related]
5. Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction.
Dathan-Stumpf A; Czarnowsky V; Hein V; Andraczek T; Stepan H
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1037-S1047.e2. PubMed ID: 33892922
[TBL] [Abstract][Full Text] [Related]
6. Eculizumab for the treatment of preeclampsia/HELLP syndrome.
Burwick RM; Feinberg BB
Placenta; 2013 Feb; 34(2):201-3. PubMed ID: 23228435
[TBL] [Abstract][Full Text] [Related]
7. Complement-Mediated Disorders in Pregnancy.
Amari Chinchilla K; Vijayan M; Taveras Garcia B; Jim B
Adv Chronic Kidney Dis; 2020 Mar; 27(2):155-164. PubMed ID: 32553248
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report.
Lokki AI; Haapio M; Heikkinen-Eloranta J
Front Immunol; 2020; 11():548. PubMed ID: 32308654
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
[TBL] [Abstract][Full Text] [Related]
10. Cerebral biomarkers in neurologic complications of preeclampsia.
Bergman L; Hastie R; Bokström-Rees E; Zetterberg H; Blennow K; Schell S; Imberg H; Langenegger E; Moodley A; Walker S; Tong S; Cluver C
Am J Obstet Gynecol; 2022 Aug; 227(2):298.e1-298.e10. PubMed ID: 35257666
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction.
Herraiz I; Dröge LA; Gómez-Montes E; Henrich W; Galindo A; Verlohren S
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):265-273. PubMed ID: 25004342
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.
Vaught AJ; Gavriilaki E; Hueppchen N; Blakemore K; Yuan X; Seifert SM; York S; Brodsky RA
Exp Hematol; 2016 May; 44(5):390-8. PubMed ID: 26921648
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in relation to development of preeclampsia.
Haeger M; Unander M; Bengtsson A
Obstet Gynecol; 1991 Jul; 78(1):46-9. PubMed ID: 2047067
[TBL] [Abstract][Full Text] [Related]
14. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
Haeger M; Unander M; Norder-Hansson B; Tylman M; Bengtsson A
Obstet Gynecol; 1992 Jan; 79(1):19-26. PubMed ID: 1727579
[TBL] [Abstract][Full Text] [Related]
15. Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
Ari E; Yilmaz Y; Gul A; Alahdab YO; Kedrah AE; Macunluoglu B; Aydin A; Arikan H; Ozener C
Am J Reprod Immunol; 2009 Oct; 62(4):238-42. PubMed ID: 19703145
[TBL] [Abstract][Full Text] [Related]
16. Proteasome Levels and Activity in Pregnancies Complicated by Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Thrombocytopenia (HELLP) Syndrome.
Berryman K; Buhimschi CS; Zhao G; Axe M; Locke M; Buhimschi IA
Hypertension; 2019 Jun; 73(6):1308-1318. PubMed ID: 31067191
[TBL] [Abstract][Full Text] [Related]
17. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
[TBL] [Abstract][Full Text] [Related]
18. Soluble fms-like tyrosine kinase 1 (sFlt-1): A novel biochemical marker for acute fatty liver of pregnancy.
Trottmann F; Raio L; Amylidi-Mohr S; Mosimann B; Jarquin Campos A; Messerli FH; Risch L; Baumann MU
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1876-1884. PubMed ID: 34157141
[TBL] [Abstract][Full Text] [Related]
19. A review of the alternative pathway of complement and its relation to HELLP syndrome: is it time to consider HELLP syndrome a disease of the alternative pathway.
Vaught AJ; Braunstein E; Chaturvedi S; Blakemore K; Brodsky RA
J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1392-1400. PubMed ID: 32338085
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.
Lisonkova S; Bone JN; Muraca GM; Razaz N; Wang LQ; Sabr Y; Boutin A; Mayer C; Joseph KS
Am J Obstet Gynecol; 2021 Nov; 225(5):538.e1-538.e19. PubMed ID: 33974902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
